3M Company vs Johnson & Johnson
MMM vs JNJ — side-by-side comparison from reported financials. MMM leads 4, JNJ leads 7 of 11 comparable metrics.
3M Company
MMM · Healthcare
$160.20-2.07%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | MMM | JNJ |
|---|---|---|
| Price | $160.20 | $261.79 |
| Market cap | $82.6B | $631B |
| Revenue (TTM) | $25.2B | $97.9B |
| Revenue growth | -1.6% | +5.6% |
| Net margin | 11.9% | 21.5% |
| Free cash flow | $3.98B | $22.2B |
| Net cash (debt) | ($4.67B) | ($27.8B) |
| 1-year price return | +4.8% | +37.0% |
| P/E | 27.5 | 29.9 |
| P/E vs own history (cheap-side %) | 18% | 16% |
| Dividend yield | 1.93% | 2.00% |
| Return on equity | 77% | 26% |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 60,500 | 140,800 |
Full résumé-style profiles: MMM CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.